Noradrenergic activity in anticipatory nausea

J. H. Fetting, Michael Edward Stefanek, V. R. Sheidler, J. D. Elsworth, S. Piantadosi, R. H. Roth

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

Original languageEnglish (US)
Pages (from-to)641-647
Number of pages7
JournalPsychosomatic Medicine
Volume54
Issue number6
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Nausea
Glycols
Clonidine
Drug Therapy
Cross-Over Studies
Placebos
Neoplasms

Keywords

  • 3-methoxy-4- hydroxyphenyl-glycol (MHPG)
  • anticipatory nausea and vomiting
  • clonidine
  • norepinephrine

ASJC Scopus subject areas

  • Applied Psychology
  • Psychiatry and Mental health

Cite this

Fetting, J. H., Stefanek, M. E., Sheidler, V. R., Elsworth, J. D., Piantadosi, S., & Roth, R. H. (1992). Noradrenergic activity in anticipatory nausea. Psychosomatic Medicine, 54(6), 641-647. https://doi.org/10.1097/00006842-199211000-00003

Noradrenergic activity in anticipatory nausea. / Fetting, J. H.; Stefanek, Michael Edward; Sheidler, V. R.; Elsworth, J. D.; Piantadosi, S.; Roth, R. H.

In: Psychosomatic Medicine, Vol. 54, No. 6, 01.01.1992, p. 641-647.

Research output: Contribution to journalArticle

Fetting, JH, Stefanek, ME, Sheidler, VR, Elsworth, JD, Piantadosi, S & Roth, RH 1992, 'Noradrenergic activity in anticipatory nausea', Psychosomatic Medicine, vol. 54, no. 6, pp. 641-647. https://doi.org/10.1097/00006842-199211000-00003
Fetting JH, Stefanek ME, Sheidler VR, Elsworth JD, Piantadosi S, Roth RH. Noradrenergic activity in anticipatory nausea. Psychosomatic Medicine. 1992 Jan 1;54(6):641-647. https://doi.org/10.1097/00006842-199211000-00003
Fetting, J. H. ; Stefanek, Michael Edward ; Sheidler, V. R. ; Elsworth, J. D. ; Piantadosi, S. ; Roth, R. H. / Noradrenergic activity in anticipatory nausea. In: Psychosomatic Medicine. 1992 ; Vol. 54, No. 6. pp. 641-647.
@article{d59e249174034e7f882ea1d9c1358700,
title = "Noradrenergic activity in anticipatory nausea",
abstract = "Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.",
keywords = "3-methoxy-4- hydroxyphenyl-glycol (MHPG), anticipatory nausea and vomiting, clonidine, norepinephrine",
author = "Fetting, {J. H.} and Stefanek, {Michael Edward} and Sheidler, {V. R.} and Elsworth, {J. D.} and S. Piantadosi and Roth, {R. H.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1097/00006842-199211000-00003",
language = "English (US)",
volume = "54",
pages = "641--647",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Noradrenergic activity in anticipatory nausea

AU - Fetting, J. H.

AU - Stefanek, Michael Edward

AU - Sheidler, V. R.

AU - Elsworth, J. D.

AU - Piantadosi, S.

AU - Roth, R. H.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

AB - Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

KW - 3-methoxy-4- hydroxyphenyl-glycol (MHPG)

KW - anticipatory nausea and vomiting

KW - clonidine

KW - norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=0026453670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026453670&partnerID=8YFLogxK

U2 - 10.1097/00006842-199211000-00003

DO - 10.1097/00006842-199211000-00003

M3 - Article

C2 - 1333617

AN - SCOPUS:0026453670

VL - 54

SP - 641

EP - 647

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 6

ER -